| 
Results for medimmune. Search took 0.21 seconds.
2008-2009 Flu Vaccines, Approved By The FDA
in Straightfromthedoc, on August 10, 2008
...rix by GlaxoSmithKline Biologicals
FluLaval by ID Biomedical Corporation of Quebec
FluMist by MedImmune Vaccines Inc.
Fluvirin by Novartis Vaccines and Diagnostics Limited
Fluzone by San...
Nasal Influenza Vaccine Flumist®, Now FDA-Approved for Children Ages 2-5
in Straightfromthedoc, on September 20, 2007
...d is sprayed in the nose.
Find more details from the FDA News .
Flumist® is a product of MedImmune Vaccines, Inc. .
[Photo Credit: Nature ]...
标准普尔将苹果纳入 S&P 100 指数
in M2 十字街口, on 2007-06-05
...普尔）于上周宣布 Apple 将纳入 S&P 100 指数。Apple 将取代 MedImmune 美国生物制药公司，这家企业目前面临被 Anglo-Swedish 集团阿斯利康公司收购的危机。...
MedImmune Considers Sale
in The Biotech Weblog, on April 13, 2007
...
MedImmune , the makers of the inhaled influenza vaccine FluMist, is considering acquisition offers from third parties . It has hired Goldman Sachs & Co. and the law firm Dewey Ballant...
MedImmune's Investigational Intranasal Influenza Vaccine, CAIV-T (cold adapted influenza vaccine, trivalent) Led to Higher Antibody Responses in Young Children Compared to Injectable
in Straightfromthedoc, on October 17, 2006
... A study recently announced by MedImmune, Inc. (Nasdaq: MEDI ) revealed higher influenza serum antibody responses in children receiving the company's next-generation, investigational intranas...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...s," said Steven Harr, a Morgan Stanley analyst.
Among Morgan Stanley's top picks were:
MedImmune : Products include biopharmaceuticals for infectious diseases, oncology and immunology ...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
..., Ph.D., Human Genome Sciences
4. Sol J. Barer, Ph.D., Celgene
5. Wayne T. Hockmeyer, Ph.D., MedImmune
$20-50 Million
6. Leonard Schleifer, M.D., Ph.D., Regeneron Pharmaceuticals
...
FDA Advisory Panel Approves Gardasil Vaccine Against Cervical Cancer
in The Biotech Weblog, on May 20, 2006
...ontrolling its prevalence.
On the business scene:
Some investors have been bidding up shares of MedImmune (nasdaq: MEDI - news - people ), the Gaithersburg , Md.-based maker of a drug for tre...
Novartis Receives $220M Grant To Develop Cell-Culture Derived Flu Vaccine
in The Biotech Weblog, on May 5, 2006
...andemic does occur. The government will be tapping on Novartis to provide about a quarter of that ( MedImmune, Inc, DynPort Vaccine Co., GlaxoSmithKline PLC, and Solvay Pharmaceuticals are the 4 other...
CSL Limited Enters Flu Vaccine Market
in The Biotech Weblog, on February 7, 2006
...arma companies such as Sanofi pasteur, GlaxoSmithKline and Chiron are revving up their productions. MedImmune even had a nasal spray version of the flu vaccine developed.
McNamee [CSL's chief e...
FDA Approves MedImmune's UK Influenza Vaccine Manufacturing Facility
in The Biotech Weblog, on January 3, 2006
...
Medimmune announced last week that the US FDA has approved its newly constructed influenza vaccine manufacturing facility in England, enabling them to to produce up to 15 million bulk do...
Improved Nasal Flu Vaccine From MedImmune
in The Biotech Weblog, on December 13, 2005
... MedImmune's shares went up as much as 8% as it announced the preliminary data from a late-stage, or Phase 3, study of their flu vaccine, CAIV-T (cold adapted influenza vaccine, trivalent). In...